Log in
Enquire now

List of Meiji Seika Pharma patents

List of Meiji Seika Pharma patents
List of BIOLASE TECHNOLOGY, INC. patents
List of NuVasive patents
List of KDDI patents
Educational consultant venture capital investors
CEOs of biogas companies
Patents where
Current Assignee
Name
is
Meiji Seika PharmaMeiji Seika Pharma
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8728794 Strain conferring anti-disease properties to host and bacterial cell composition

Patent 8728794 was granted and assigned to Meiji Seika Pharma on May, 2014 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
8728794
May 20, 2014
‌
US Patent 9708320 β-lactamase inhibitor and process for preparing the same

Patent 9708320 was granted and assigned to Meiji Seika Pharma on July, 2017 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9708320
July 18, 2017
‌
US Patent 10000492 Process for producing diazabicyclooctane derivative

Patent 10000492 was granted and assigned to Meiji Seika Pharma on June, 2018 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10000492
June 19, 2018
‌
US Patent 10131665 Processes for producing diazabicyclooctane compounds

Patent 10131665 was granted and assigned to Meiji Seika Pharma on November, 2018 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10131665
November 20, 2018
‌
US Patent 10023573 Beta-lactamase inhibitor and process for preparing the same

Patent 10023573 was granted and assigned to Meiji Seika Pharma on July, 2018 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10023573
July 17, 2018
‌
US Patent 10294224 Lyophilized composition of a diazabicyclooctane compound and process of producing the same

Patent 10294224 was granted and assigned to Meiji Seika Pharma on May, 2019 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10294224
May 21, 2019
‌
US Patent 10556905 Processes for preparing a diazabicyclooctane compound

Patent 10556905 was granted and assigned to Meiji Seika Pharma on February, 2020 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10556905
February 11, 2020
‌
US Patent 10000491 Process for producing diazabicyclooctane derivative and intermediate thereof

Patent 10000491 was granted and assigned to Meiji Seika Pharma on June, 2018 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10000491
June 19, 2018
‌
US Patent 9676777 Compounds useful for producing an optically active diazabicyclooctane compound

Patent 9676777 was granted and assigned to Meiji Seika Pharma on June, 2017 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9676777
June 13, 2017
‌
US Patent 9035062 Process for preparing a compound useful for producing an optically active diazabicyclooctane compound

Patent 9035062 was granted and assigned to Meiji Seika Pharma on May, 2015 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9035062
May 19, 2015
‌
US Patent 9540617 Method for producing horseradish peroxidase recombinant protein using filamentous fungus

Patent 9540617 was granted and assigned to Meiji Seika Pharma on January, 2017 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9540617
January 10, 2017
‌
US Patent 9181250 Beta-lactamase inhibitor and process for preparing the same

Patent 9181250 was granted and assigned to Meiji Seika Pharma on November, 2015 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9181250
November 10, 2015
‌
US Patent 9328068 N-[1-((6-chloropyridin-3-yl) methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of animal parasitic pests and agricultural/horticultural pests

Patent 9328068 was granted and assigned to Meiji Seika Pharma on May, 2016 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9328068
May 3, 2016
‌
US Patent 9751907 Arbekacin derivative, and production and use thereof

Patent 9751907 was granted and assigned to Meiji Seika Pharma on September, 2017 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9751907
September 5, 2017
‌
US Patent 8957214 Pest control agent

Patent 8957214 was granted and assigned to Meiji Seika Pharma on February, 2015 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
8957214
February 17, 2015
‌
US Patent 9717242 N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests

Patent 9717242 was granted and assigned to Meiji Seika Pharma on August, 2017 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9717242
August 1, 2017
‌
US Patent 9315785 Pyripyropene a biosynthetic gene

Patent 9315785 was granted and assigned to Meiji Seika Pharma on April, 2016 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9315785
April 19, 2016
‌
US Patent 9073866 Pest control agent

Patent 9073866 was granted and assigned to Meiji Seika Pharma on July, 2015 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9073866
July 7, 2015
‌
US Patent 10349655 Pest control composition including novel iminopyridine derivative

Patent 10349655 was granted and assigned to Meiji Seika Pharma on July, 2019 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10349655
July 16, 2019
‌
US Patent 8710198 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof

Patent 8710198 was granted and assigned to Meiji Seika Pharma on April, 2014 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
8710198
April 29, 2014
‌
US Patent 9434739 Systemic insecticide

Patent 9434739 was granted and assigned to Meiji Seika Pharma on September, 2016 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9434739
September 6, 2016
‌
US Patent 10085449 N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

Patent 10085449 was granted and assigned to Meiji Seika Pharma on October, 2018 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10085449
October 2, 2018
‌
US Patent 10562858 Crystalline anti-trichophyton agents and preparation process thereof

Patent 10562858 was granted and assigned to Meiji Seika Pharma on February, 2020 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10562858
February 18, 2020
‌
US Patent 9255115 Method for producing glufosinate P free acid

Patent 9255115 was granted and assigned to Meiji Seika Pharma on February, 2016 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9255115
February 9, 2016
‌
US Patent 9284273 Compounds useful for producing an optically active diazabicyclooctane compound

Patent 9284273 was granted and assigned to Meiji Seika Pharma on March, 2016 by the United States Patent and Trademark Office.

Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
Meiji Seika Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9284273
March 15, 2016
Results per page:
72 results
0 selected
72 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us